Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

New drug helps treat pancreatic cancer

Digest more
Top News
Overview
Reactions and opinions
 · 6h · on MSN
Pancreatic cancer 'miracle' drug daraxonrasib doubles survival rate in new trial
An experimental drug nearly doubled the overall survival rates of pancreatic cancer patients, according to the results of its latest clinical trial.

Continue reading

 · 9h
New drug nearly doubles survival rates in some pancreatic cancer patients, study says
 · 15h
Revolution Medicines Shares Rise on Pancreatic Cancer Drug Trial Results
 · 22h
Daily pill doubles survival time for pancreatic cancer patients
A pill has been found to almost double the survival time for advanced pancreatic cancer patients, with experts describing the trial as a game changer.

Continue reading

Science News · 1d
A new pancreatic cancer pill may be a game changer for patients
 · 1d
Revolution's pancreatic cancer drug doubles survival, boosts quality of life
ScienceAlert · 1d
Breakthrough Pill Nearly Doubles Survival Time For One of The Deadliest Cancers
"Having treated pancreatic cancer for 16 years, I actually started crying" when first seeing the study results, Dr. Rachna Shroff of the University of Arizona Cancer Center, who wasn't involved with ...

Continue reading

 · 13h
New cancer pill almost doubles survival time for pancreatic patients during trial
 · 1d
New pill nearly doubles survival time for pancreatic cancer patients
16hon MSN

Doctors stood up and cheered mid-presentation for this historic pancreatic cancer treatment

The announcement of a successful late-stage treatment that nearly doubles the survival for patients with deadly pancreatic cancer brought an audience of doctors and other global oncology professions to their feet on Sunday.
6hon MSN

J&J prostate cancer drug reduces risk of cancer spread and death in late-stage study

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six months before and after prostate surgery improved the chances of eliminating the cancer and reduced the risk of disease progression or death,
4hon MSN

Targeted therapy reduces risk of lung cancer recurrence by 83% in rare genetic subtype

A new study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center shows that the targeted cancer drug selpercatinib can significantly reduce the risk of lung cancer returning in patients with a rare genetic subtype of early-stage non-small cell lung cancer (NSCLC),
3h

Experimental pill promises new hope for deadly pancreatic cancer

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of cancer. “While not curing the cancer,
7hon MSN

A personalized vaccine for melanoma cut the risk of cancer returning after five years

An experimental vaccine from Moderna shows promise in keeping deadly skin cancer from returning for years, according to new clinical trial results.
WebMD
1y

Hormone Therapy for Endometrial Cancer: What to Know

Your doctor may prescribe hormone therapy if you have late-stage cancer and sometimes if you have working ovaries and want to get pregnant. Photo Credit: iStock/Getty Images Hormone therapy for endometrial cancer helps control or stop the growth of cancer ...
19h

Great-grandmother with ‘inoperable’ tumour receives UK-first cancer treatment

Brenda Iveson was initially told conventional cancer therapies would be ineffective against the six-centimetre tumour in her liver
55m

BioInvent International AB (publ) (BOVNF) Discusses Ovarian Cancer Treatment Landscape and TNFR2-Targeted Therapies in Solid Tumors Transcript

BioInvent International AB (publ) ( BOVNF) Discusses Ovarian Cancer Treatment Landscape and TNFR2-Targeted Therapies in Solid Tumors May 27, 2026 8:00 AM EDT Good morning, and welcome to the BioInvent KOL Event. [Operator Instructions]
  • Privacy
  • Terms